Wernli Miri Halperin

CIK 1897615 · Executive President · last filed 2024-08-22

Wernli Miri Halperin is an Executive President who has filed 5 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for MNMD, was dated Aug 22, 2024.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

1

Total Filings

5

Lifetime Open-Market Net

$0

Filer Profile

Reported Address

C/O MIND MEDICINE INC.
ONE WORLD TRADE CENTER, SUITE 8500
NEW YORK, NY 10007

Formerly Known As

Wernli Miri Halperin (2022–2024)

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Definium Therapeutics, Inc. (MNMD) Delisted	Executive President	235,000	$15.00	$3.52M	$0	5	2024-08-22

Recent Filings

5 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-08-22	Definium Therapeutics, Inc. (MNMD) Delisted	Mixed	+17,405	-$16.1K	EDGAR
2024-02-29	Definium Therapeutics, Inc. (MNMD) Delisted	Grant (A)	—	$0	EDGAR
2023-04-24	Definium Therapeutics, Inc. (MNMD) Delisted	Grant (A)	+100,000	$0	EDGAR
2023-03-17	Definium Therapeutics, Inc. (MNMD) Delisted	Grant (A)	+100,000	$0	EDGAR
2022-03-28	Definium Therapeutics, Inc. (MNMD) Delisted	Grant (A)	+600,000	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.